← Back to all trials
Active Not Recruiting
NCT07213648
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
Conditions: Huntington Disease, Parkinson Disease
Sex: All
Ages: 21 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 136
Sponsor: University of Virginia
Location: Univeristy of Virginia School of Nursing Charlottesville Virginia
Summary
The purpose of this study is to assess preliminary efficacy of a tailored cognitive bias modification for interpretation (CBM-I) app for reducing anxiety in Huntington's disease and Parkinson's disease.
Eligibility Criteria
Inclusion Criteria:
* Clinical diagnosis of Huntington's disease or Parkinson's disease (genetic diagnosis of HD also acceptable)
* With anxiety symptoms (NeuroQoL Anxiety ≥12)
Exclusion Criteria:
* Cognitive decline precluding ability to consent or complete the intervention (MoCA 5 min/telephone ≤11)
* Unable to read and understand English
* Does not have regular access to an internet-connected device, capable of downloading and installing the mobile application (i.e., tablet or iPhone running iOS 10 or later or an Android phone running Android 5.0 or later)
* Not located in the USA
* \
Source: ClinicalTrials.gov (NCT07213648). StuddyBuddy aggregates publicly available trial information.
